540204 — Eiko Lifesciences Share Price
0.000.00%
Last trade - 00:00- IN₹725.28m
- IN₹664.04m
- IN₹279.29m
- 24
- 25
- 33
- 14
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.34 | ||
| Price to Tang. Book | 1.34 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.03 | ||
| EV to EBITDA | 36.44 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 2.03% | ||
| Return on Equity | 2.61% | ||
| Operating Margin | 3.11% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | n/a | 119.91 | 254.12 | 183.21 | 279.29 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | +380.72 | -43.82 | +1.83 | -8.63 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Eiko LifeSciences Limited is an India-based company engaged in manufacturing, processing, formulating, producing, buying, selling, and exporting specialty and fine chemicals. It operates in the Specialty & Fine Chemicals segment. It offers products in Specialty Chemicals and Intermediates, Application Programming Interfaces (APIs), Agrochemical Intermediates, Flavor & Fragrances, and Cosmetic Emollients. Specialty Chemicals and Intermediates include Lasamide, Trichloro Salicylic acid, Chloroacetyl Xylidide and Thiodipropionic acid. Agrochemical Intermediates include 5-chloro-8-hydroxyquinoline. Cosmetic Emollients include Isopropyl Oleate, Isopropyl Laurate, Isopropyl Palmitate, Isopropyl Myristate, Methyl Myristate, Butyl Oleate, Butyl Laurate, and Methyl Myristate, among others. APIs include Topiramate Indian Pharmacopoeia (IP), (United States Pharmacopeia) USP/ European Pharmacopeia (EP), and Glucosamine hydrochloride (HCL)/Sodium/Potassium USP/EP, among others.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- January 7th, 1977
- Public Since
- December 13th, 2016
- No. of Employees
- 3
- Sector
- Chemicals
- Industry
- Basic Materials
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 13,720,854
- Address
- 2055-56, 3Rd Floor,, NEW DELHI, 110055
- Web
- https://www.eikolifesciences.com/
- Phone
- +91 2225438095
- Auditors
- Thanawala & Company
Upcoming Events for 540204
Q1 2026 Eiko Lifesciences Ltd Earnings Release
Eiko Lifesciences Ltd Annual Shareholders Meeting
Q2 2026 Eiko Lifesciences Ltd Earnings Release
Similar to 540204
3B Blackbio DX
Bombay Stock Exchange
A-1
Bombay Stock Exchange
Add-Shop E-Retail
Bombay Stock Exchange
Advance Petrochemicals
Bombay Stock Exchange
Advance Syntex
Bombay Stock Exchange
FAQ
What is the Eiko Lifesciences share price?
As of Today at 20:23 UTC, shares in Eiko Lifesciences are trading at IN₹50.00. This share price information is delayed by 15 minutes.
How has the Eiko Lifesciences share price performed this year?
Shares in Eiko Lifesciences last closed at IN₹50.00 and the price had moved by -10.04% over the past 365 days. In terms of relative price strength the Eiko Lifesciences share price has underperformed the S&P BSE 100 Index by -15.26% over the past year.
What are the analyst and broker recommendations for Eiko Lifesciences?
There is no consensus recommendation for this security.
Find out moreWhat is the Eiko Lifesciences dividend yield?
Eiko Lifesciences does not currently pay a dividend.
Does Eiko Lifesciences pay a dividend?
Eiko Lifesciences does not currently pay a dividend.
When does Eiko Lifesciences next pay dividends?
Eiko Lifesciences does not currently pay a dividend.
How do I buy Eiko Lifesciences shares?
To buy shares in Eiko Lifesciences you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Eiko Lifesciences?
As of the previous close price of IN₹50.00, shares in Eiko Lifesciences had a market capitalisation of IN₹725.28m.
Where are Eiko Lifesciences shares listed?
Here are the trading details for Eiko Lifesciences:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 540204
What kind of share is Eiko Lifesciences?
Based on an overall assessment of its quality, value and momentum Eiko Lifesciences is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Eiko Lifesciences share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Eiko Lifesciences share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Eiko Lifesciences. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -17.22%.
As of the last closing price of IN₹50.00, shares in Eiko Lifesciences were trading -14.32% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Eiko Lifesciences PE Ratio?
The Eiko Lifesciences PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹50.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Eiko Lifesciences?
We do not have data on Eiko Lifesciences' directors